Can metformin lower blood pressure
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Can Metformin Lower Blood Pressure?
Metformin, a widely used medication for managing type 2 diabetes, has been investigated for its potential effects on blood pressure (BP). This article synthesizes findings from various studies to determine whether metformin can lower blood pressure in different populations.
Metformin and Systolic Blood Pressure Reduction
Several studies have shown that metformin can significantly reduce systolic blood pressure (SBP). A meta-analysis of randomized controlled trials involving nondiabetic patients found that metformin significantly lowered SBP by an average of 1.98 mmHg, particularly in individuals with impaired glucose tolerance or obesity. This effect was more pronounced in patients with a body mass index (BMI) of 30 kg/m² or higher, with reductions of up to 5.03 mmHg.
Metformin's Impact on Diastolic Blood Pressure
The same meta-analysis indicated that metformin did not have a significant effect on diastolic blood pressure (DBP). This finding was consistent across various subgroups, suggesting that while metformin may lower SBP, its impact on DBP is minimal.
Animal Studies: Insights from Hypertensive Models
Animal studies have provided additional insights into metformin's blood pressure-lowering effects. In spontaneously hypertensive rats, metformin was shown to blunt the rise in blood pressure induced by a high-salt diet, suggesting its potential in managing salt-sensitive hypertension. Another study in streptozotocin-induced diabetic rats demonstrated that metformin reduced blood pressure and improved endothelial function, which could contribute to its antihypertensive effects.
Clinical Trials in Hypertensive Patients
Clinical trials in hypertensive patients without diabetes have yielded mixed results. One randomized clinical trial found no significant reduction in blood pressure measured by ambulatory blood pressure monitoring (ABPM) after 8 weeks of metformin treatment. However, another study in obese, hypertensive women reported significant reductions in both blood pressure and left ventricular mass after 12 weeks of metformin treatment, suggesting potential cardiovascular benefits in this subgroup.
Mechanisms of Blood Pressure Reduction
The mechanisms by which metformin may lower blood pressure are multifaceted. Metformin has been shown to reduce sympathetic neural outflow, which can lower blood pressure. It also improves endothelial function and increases antioxidant enzyme activity, which can contribute to vascular health and lower blood pressure. Additionally, metformin's ability to improve insulin sensitivity and reduce body weight may indirectly contribute to its antihypertensive effects.
Conclusion
In summary, metformin appears to have a modest but significant effect on lowering systolic blood pressure, particularly in individuals with impaired glucose tolerance or obesity. Its impact on diastolic blood pressure is less clear, with most studies showing no significant effect. The antihypertensive effects of metformin are likely mediated through multiple mechanisms, including reduced sympathetic activity, improved endothelial function, and enhanced insulin sensitivity. While more research is needed to fully understand these effects, metformin may offer additional cardiovascular benefits beyond its glucose-lowering properties.
Sources and full results
Most relevant research papers on this topic